Search research articles
Contact Us
Filters
Showing results (671-680 of 783) with videos related to
Page
of 79
Sort By:
Molecular Human Reproduction
|
April 13, 2017
Deregulation of the endometrial stromal cell secretome precedes embryo implantation failure
Ruban Rex Peter Durairaj, Asma Aberkane, Lukasz Polanski, et al.
Archives of Disease in Childhood
|
March 12, 2020
Clinical features and management of children with primary ciliary dyskinesia in England
Bruna Rubbo, Sunayna Best, Robert Anthony Hirst, et al.
ERJ Open Research
|
March 29, 2021
COVID-PCD: a participatory research study on the impact of COVID-19 in people with primary ciliary dyskinesia
Eva S L Pedersen, Eugénie N R Collaud, Rebeca Mozun, et al.
Gut
|
April 12, 2012
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
S Lucas Goede, Aafke H C van Roon, Jacqueline C I Y Reijerink, et al.
Endocrinology
|
August 14, 2014
Decidualization induces a secretome switch in perivascular niche cells of the human endometrium
Keisuke Murakami, Yie Hou Lee, Emma S Lucas, et al.
Inflammatory Bowel Diseases
|
August 20, 2014
Barriers and facilitators to successful transition from pediatric to adult inflammatory bowel disease care from the perspectives of providers
Christine W Paine, Natalie B Stollon, Matthew S Lucas, et al.
Molecular Human Reproduction
|
August 17, 2017
Deregulation of the endometrial stromal cell secretome precedes embryo implantation failure
Ruban Rex Peter Durairaj, Asma Aberkane, Lukasz Polanski, et al.
ERJ Open Research
|
December 2, 2021
Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review
Florian Gahleitner, James Thompson, Claire L Jackson, et al.
BMC Medical Genomics
|
September 24, 2021
Whole genome sequencing in the diagnosis of primary ciliary dyskinesia
Gabrielle Wheway, N Simon Thomas, Mary Carroll, et al.
Leukemia & Lymphoma
|
October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia
Thomas S Lin, Wendy Stock, Huiping Xu, et al.
Page
of 79
Search research articles
Search
Showing results (671-680 of 783) with videos related to
Sort By:
Page
of 79
Molecular Human Reproduction
|
April 13, 2017
Deregulation of the endometrial stromal cell secretome precedes embryo implantation failure
Ruban Rex Peter Durairaj, Asma Aberkane, Lukasz Polanski, et al.
Archives of Disease in Childhood
|
March 12, 2020
Clinical features and management of children with primary ciliary dyskinesia in England
Bruna Rubbo, Sunayna Best, Robert Anthony Hirst, et al.
ERJ Open Research
|
March 29, 2021
COVID-PCD: a participatory research study on the impact of COVID-19 in people with primary ciliary dyskinesia
Eva S L Pedersen, Eugénie N R Collaud, Rebeca Mozun, et al.
Gut
|
April 12, 2012
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
S Lucas Goede, Aafke H C van Roon, Jacqueline C I Y Reijerink, et al.
Endocrinology
|
August 14, 2014
Decidualization induces a secretome switch in perivascular niche cells of the human endometrium
Keisuke Murakami, Yie Hou Lee, Emma S Lucas, et al.
Inflammatory Bowel Diseases
|
August 20, 2014
Barriers and facilitators to successful transition from pediatric to adult inflammatory bowel disease care from the perspectives of providers
Christine W Paine, Natalie B Stollon, Matthew S Lucas, et al.
Molecular Human Reproduction
|
August 17, 2017
Deregulation of the endometrial stromal cell secretome precedes embryo implantation failure
Ruban Rex Peter Durairaj, Asma Aberkane, Lukasz Polanski, et al.
ERJ Open Research
|
December 2, 2021
Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review
Florian Gahleitner, James Thompson, Claire L Jackson, et al.
BMC Medical Genomics
|
September 24, 2021
Whole genome sequencing in the diagnosis of primary ciliary dyskinesia
Gabrielle Wheway, N Simon Thomas, Mary Carroll, et al.
Leukemia & Lymphoma
|
October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia
Thomas S Lin, Wendy Stock, Huiping Xu, et al.
Page
of 79